An evaluation of priscoline by artery in the treatment of peripheral arterial obliterative disease.
D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001158:Arteries; D002319:Cardiovascular System; D004692:Endarteritis / Q000628:therapy*; D006801:Humans; D013565:Sympatholytics / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans; D014043:Tolazoline
D013565:Sympatholytics; D014043:Tolazoline
ENDARTERITIS OBLITERANS/therapy; SYMPATHOLYTICS/therapeutic use